Lineage, Inc. - Common Stock (LINE)
41.64
-1.16 (-2.71%)
NASDAQ · Last Trade: Aug 10th, 1:46 PM EDT
Detailed Quote
Previous Close | 42.80 |
---|---|
Open | 43.18 |
Bid | 40.29 |
Ask | 42.46 |
Day's Range | 41.54 - 44.60 |
52 Week Range | 40.49 - 88.57 |
Volume | 1,702,842 |
Market Cap | 9.54B |
PE Ratio (TTM) | -15.89 |
EPS (TTM) | -2.6 |
Dividend & Yield | 2.112 (5.07%) |
1 Month Average Volume | 1,170,520 |
Chart
About Lineage, Inc. - Common Stock (LINE)
Lineage, Inc. is a biotech company focused on advancing regenerative medicine and developing therapeutic solutions for patients with degenerative diseases and injuries. The company utilizes innovative technologies, including stem cell research and tissue engineering, to create treatments aimed at restoring function and improving quality of life. Through its research and development efforts, Lineage seeks to bring groundbreaking therapies to market, addressing unmet medical needs in various fields such as ophthalmology, neurology, and orthopedics. By leveraging scientific advancements and collaborative partnerships, Lineage continues to work towards its mission of transforming medicine and enhancing patient outcomes. Read More
News & Press Releases
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 9, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 8, 2025
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) common stock pursuant and/or traceable to the registration statement used in connection with the Company’s July 2024 initial public offering (the “IPO”). Lineage investors have until September 30, 2025 to file a lead plaintiff motion.
By Glancy Prongay & Murray LLP · Via Business Wire · August 8, 2025
NEW YORK - August 8, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Lineage, Inc. (NASDAQ: LINE) of a class action securities lawsuit.
Via TheNewswire.com · August 8, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 8, 2025
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) common stock pursuant and/or traceable to the registration statement used in connection with the Company’s July 2024 initial public offering (the “IPO”). Lineage investors have until September 30, 2025 to file a lead plaintiff motion.
By Law Offices of Howard G. Smith · Via Business Wire · August 7, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 7, 2025
NEW YORK - August 7, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Lineage, Inc. (NASDAQ: LINE) of a class action securities lawsuit.
Via TheNewswire.com · August 7, 2025
Robbins Geller Rudman & Dowd LLP announces that purchasers of Lineage, Inc. (NASDAQ: LINE) common stock in or traceable to the registration statement used in connection with Lineage’s July 2024 initial public offering (“IPO”), have until September 30, 2025 to seek appointment as lead plaintiff of the Lineage class action lawsuit. Captioned City of St. Clair Shores Police and Fire Retirement System v. Lineage, Inc., No. 25-cv-12383 (E.D. Mich.), the Lineage class action lawsuit charges Lineage as well as certain of its top executives, directors, IPO underwriters, and IPO sponsor with violations of the Securities Act of 1933.
By Robbins Geller Rudman & Dowd LLP · Via Business Wire · August 6, 2025
Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world’s largest global temperature-controlled warehouse REIT, today announced its financial results for the second quarter of 2025.
By Lineage, Inc. · Via Business Wire · August 6, 2025
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs stockholders that a class action was filed on behalf of all purchasers of Linage, Inc. (NASDAQ: LINE) common stock in or traceable to the registration statement used in connection with the Company's 2024 initial public offering ("IPO"). Lineage is a Maryland REIT focused on temperature-controlled cold-manage facilities.
By Robbins LLP · Via GlobeNewswire · August 5, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Lineage (LINE) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · August 5, 2025
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Lineage, Inc. (NASDAQ: LINE) and certain of the Company’s senior executives and directors for potential violations of the federal securities laws.
By Bleichmar Fonti & Auld LLP · Via Business Wire · August 5, 2025
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 5, 2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) in, or traceable to, the registration statement issued in connection with the Company’s July 2024 initial public offering (the “IPO”).
By Bernstein Liebhard LLP · Via GlobeNewswire · August 4, 2025
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Lineage, Inc. (“Lineage” or “the Company”) (NASDAQ: LINE) for violations of the federal securities laws.
By The Schall Law Firm · Via Business Wire · August 3, 2025
Robbins Geller Rudman & Dowd LLP announces that purchasers of Lineage, Inc. (NASDAQ: LINE) common stock in or traceable to the registration statement used in connection with Lineage’s July 2024 initial public offering (the “IPO”), have until September 30, 2025 to seek appointment as lead plaintiff of the Lineage class action lawsuit. Captioned City of St. Clair Shores Police and Fire Retirement System v. Lineage, Inc., No. 25-cv-12383 (E.D. Mich.), the Lineage class action lawsuit charges Lineage and certain of its top executives, directors, IPO underwriters, and IPO sponsor with violations of the Securities Act of 1933.
By Robbins Geller Rudman & Dowd LLP · Via Business Wire · August 1, 2025
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 1, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · July 28, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PetMed (PETS), GeneDx (WGS), Lineage (LINE), or Proficient Auto (PAL) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · July 23, 2025
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · July 23, 2025
NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · July 18, 2025